41 results
8-K
EX-1.1
ALRN
Aileron Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
5:25pm
.
Section 5. Miscellaneous.
a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends
8-K
EX-4.1
ALRN
Aileron Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
5:25pm
notice to the contrary.
Section 5. Miscellaneous.
a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting … rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
424B5
ALRN
Aileron Therapeutics Inc
1 May 24
Prospectus supplement for primary offering
5:24pm
of warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until such warrant holders exercise their warrants … , 90,823,597 shares of common stock were outstanding and no shares of preferred stock were outstanding.
Common Stock
Voting Rights. Holders of our common
FWP
ALRN
Aileron Therapeutics Inc
1 May 24
Free writing prospectus
8:54am
the rights or privileges of holders of our common stock, including any voting rights, until such warrant holders exercise their warrants.
Waivers
8-K/A
EX-99.3
wn27gdcp
11 Jan 24
Index to Consolidated Financial Statements
4:18pm
8-K
EX-3.1
itj07miu08tqidk s8lm
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
r5h5tdl7 s4
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
424B5
rznk59 a8
21 Jun 22
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
8np1 aaxc0c5g5i
17 Jun 21
Departure of Directors or Certain Officers
4:12pm